Ocular Therapeutix holder plans $11K stock sale

OCULAR THERAPEUTIX, INC (OCUL) has a notice of proposed sale of common stock filed under Rule 144 on behalf of Donald D. Notman Jr.

Rhea-AI Filing Summary

OCULAR THERAPEUTIX, INC (OCUL) has a notice of proposed sale of common stock filed under Rule 144 on behalf of Donald D. Notman Jr. The filing covers 1,099 shares of common stock, described as restricted stock vesting under a registered plan, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services. The reported transaction date is August 31, 2026, with an indicated total value of $11,251.89.

Key Figures

Shares of common stock: 1,099 shares Total value of securities: $11,251.89 Vesting date: 08/29/2026 +1 more

4 metrics

Shares of common stock 1,099 shares Number of OCULAR THERAPEUTIX, INC common shares covered by the Form 144 notice

Total value of securities $11,251.89 Reported value associated with 1,099 OCUL common shares in the securities information section

Vesting date 08/29/2026 Date when restricted stock vests under a registered plan

Reported transaction date 08/31/2026 Date tied to the securities information for the proposed sale

Key Terms

Rule 144, restricted stock, registered plan, Form 144

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock financial

"Restricted Stock Vesting Under a Registered Plan"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

registered plan financial

"Restricted Stock Vesting Under a Registered Plan"

A registered plan is a savings or investment account that a government recognizes for special tax treatment and rules, such as limits on how much you can put in and conditions for withdrawals. For investors it matters because those rules change how much of your gains are taxed, how quickly your money can be accessed and what strategies make sense — like a labeled jar that gives tax breaks but comes with rules about when and how you can take the money out.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for OCUL?

The Form 144 filing for OCULAR THERAPEUTIX, INC (OCUL) discloses a proposed sale under Rule 144 by Donald D. Notman Jr. of 1,099 shares of common stock, arising from restricted stock vesting under a registered plan, to be handled by Morgan Stanley Smith Barney LLC.

How many OCUL shares are covered by this Form 144 notice?

The notice covers 1,099 shares of OCULAR THERAPEUTIX, INC common stock, with a reported total value of $11,251.89 in the securities information section.

Who is the selling security holder in the OCUL Form 144?

The selling security holder is Donald D. Notman Jr., on whose account the 1,099 shares of OCULAR THERAPEUTIX, INC common stock are proposed to be sold under Rule 144.

What is the nature of the OCUL securities to be sold under Form 144?

The securities are common stock of OCULAR THERAPEUTIX, INC, specifically described as restricted stock vesting under a registered plan, with 1,099 shares indicated in the filing.

When are the OCUL securities expected to vest and be sold?

The filing states the restricted stock vests on August 29, 2026, with the related sale information reported for August 31, 2026 under the securities information section.

Which broker is listed for handling the OCUL Form 144 sale?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, in connection with the proposed sale of OCULAR THERAPEUTIX, INC common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 04:03 PM EDT Accepted by SEC EDGAR 08/31/2026 - 04:02 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001718019
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OCULAR THERAPEUTIX, INC.
SEC File Number	001-36554
Address of Issuer	14 CROSBY DRIVE, 3RD FLOOR BEDFORD MASSACHUSETTS 01730
Phone	781-357-4000
Name of Person for Whose Account the Securities are To Be Sold	DONALD D NOTMAN JR.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1099	11251.89	219615868	08/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/29/2026	Restricted Stock Vesting Under a Registered Plan	Issuer			1099	08/29/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Donald D Notman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)